BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 28240396)

  • 1. Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
    Kiang KM; Tang W; Song Q; Liu J; Li N; Lam TL; Shum HC; Zhu Z; Leung GK
    Br J Cancer; 2023 May; 128(10):1955-1963. PubMed ID: 36927978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
    Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
    Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures, Occurrences and Biosynthesis of 11,12,13-Tri-
    Coca-Ruíz V; Suárez I; Aleu J; Collado IG
    Plants (Basel); 2022 Mar; 11(6):. PubMed ID: 35336651
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chang KF; Chang JT; Huang XF; Huang YC; Li CY; Weng JC; Hsiao CY; Hsu HJ; Tsai NM
    Int J Med Sci; 2021; 18(11):2417-2430. PubMed ID: 33967620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting off-target effects: endoplasmic reticulum stress and autophagy as effective strategies to enhance temozolomide treatment.
    He Y; Su J; Lan B; Gao Y; Zhao J
    Onco Targets Ther; 2019; 12():1857-1865. PubMed ID: 30881038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers.
    Avril T; Vauléon E; Chevet E
    Oncogenesis; 2017 Aug; 6(8):e373. PubMed ID: 28846078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Akt-pathway to improve radiosensitivity in glioblastoma.
    Narayan RS; Fedrigo CA; Stalpers LJ; Baumert BG; Sminia P
    Curr Pharm Des; 2013; 19(5):951-7. PubMed ID: 22973963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress‑induced cell death as a potential mechanism for targeted therapy in glioblastoma (Review).
    Shi P; Zhang Z; Xu J; Zhang L; Cui H
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.
    Grogan PT; Sarkaria JN; Timmermann BN; Cohen MS
    Invest New Drugs; 2014 Aug; 32(4):604-17. PubMed ID: 24718901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
    Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of JNK potentiates temozolomide-induced cytotoxicity in U87MG glioblastoma cells via suppression of Akt phosphorylation.
    Vo VA; Lee JW; Lee HJ; Chun W; Lim SY; Kim SS
    Anticancer Res; 2014 Oct; 34(10):5509-15. PubMed ID: 25275048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
    Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP
    Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radicol, a Novel Trinorguaiane-Type Sesquiterpene, Induces Temozolomide-Resistant Glioma Cell Apoptosis via ER Stress and Akt/mTOR Pathway Blockade.
    Li ZY; Zhang C; Chen L; Chen BD; Li QZ; Zhang XJ; Li WP
    Phytother Res; 2017 May; 31(5):729-739. PubMed ID: 28240396
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.